Pfizer CEO Albert Bourla joins “CBS Mornings” on the one-year anniversary of the first Pfizer vaccine doses administered in the U.S. He discusses Omicron concerns, boosters, and the latest data on Pfizer’s COVID antiviral pill. Pfizer says it shows the pill is highly effective in treating COVID-19 in high-risk unvaccinated adults. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.